Deep Dive: Deep Dive Into the RPH-104 Molecule

Yan Lavrovsky, MD, PhD discusses the RPH-104 Molecule, a biological project that is currently being developed to treat a variety of inflammatory diseases, metabolic diseases, recurrent fever, joint lesions, and rashes. Dr. Lavrovsky discusses why the FDA approval of the molecule is so groundbreaking, future research, and what first sparked his team’s interest in researching and developing the RPH-104 molecule.